Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
  1. 4 Option exercise Director acquired 19,000 shares (option exercise)
  2. 4 Option exercise Director acquired 19,000 shares (option exercise)
  3. 4 Option exercise Director acquired 19,000 shares (option exercise)
  4. 4 Option exercise Director acquired 19,000 shares (option exercise)
  5. 4 Option exercise Director acquired 19,000 shares (option exercise)
  6. 4 Option exercise Director acquired 19,000 shares (option exercise)
  7. 4 Option exercise Director acquired 31,000 shares (option exercise)
  8. 4 Shares withheld for taxes Chief Executive Officer gave up 28,704 shares (to pay taxes)
  9. 4 Open-market sale Director sold 5,833 shares at $1.15 ($6,708)
  10. 4 Shares withheld for taxes Chief Scientific Officer gave up 20,658 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Executive Officer gave up 25,980 shares (to pay taxes)
  12. 4 Shares withheld for taxes CFO gave up 31,410 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 42,273 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Scientific Officer gave up 27,937 shares (to pay taxes)
  15. 4 Shares withheld for taxes CFO gave up 41,123 shares (to pay taxes)
  16. 4 Open-market sale Director sold 11,668 shares at $1.28 ($14,935)
  17. 4 Derivatives Options or other derivatives
  18. 4 Option exercise Director acquired 4,273 shares (option exercise)
  19. 4 Open-market sale Director sold 11,875 shares at $2.66 ($31,588)
  20. 4 Open-market sale Director sold 2,000 shares at $2.25 ($4,500)

Page 5 of 30 · 592 filings